Prevalence and clinical implications of abnormal body composition phenotypes in patients with COVID-19: a systematic review.

ABSTRACT:

Background

The impact of body composition (BC) abnormalities on COVID-19 outcomes remains to be determined.

Objectives

We summarized the evidence on BC abnormalities and their relationship with adverse clinical outcomes in patients with COVID-19.

Methods

A systematic search was conducted up until 26 September, 2022 for observational studies using BC techniques to quantify skeletal muscle mass (or related compartments), muscle radiodensity or echo intensity, adipose tissue (AT; or related compartments), and phase angle (PhA) in adults with COVID-19. Methodological quality of studies was assessed using the Newcastle-Ottawa Scale. A synthesis without meta-analysis was conducted to summarize the prevalence of BC abnormalities and their significant associations with clinic

SUBMITTER: Montes-Ibarra M 

PROVIDER: S-EPMC10082471 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature